Michael Chambers is an angel investor with U.S. investment activity in biotechnology, life sciences and pharmaceuticals, including companies applying AI and machine learning to therapeutic development. He has acted as a lead investor in life sciences financing involving machine learning, synthetic biology and immune-based therapeutics.